Vitamin D Supplementation and Cardiovascular Disease Risk-Reply

Affiliations

¹ School of Population Health, The University of Auckland, Auckland, New Zealand.
² Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.

Comment

Robert Scragg et al. JAMA Cardiol. 2017.

. 2017 Nov 1;2(11):1282.

doi: 10.1001/jamacardio.2017.2941.

¹ School of Population Health, The University of Auckland, Auckland, New Zealand.
² Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston.

No abstract available

Comment on

Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study : A Randomized Clinical Trial.
Scragg R, Stewart AW, Waayer D, Lawes CMM, Toop L, Sluyter J, Murphy J, Khaw KT, Camargo CA Jr. Scragg R, et al. JAMA Cardiol. 2017 Jun 1;2(6):608-616. doi: 10.1001/jamacardio.2017.0175. JAMA Cardiol. 2017. PMID: 28384800 Free PMC article. Clinical Trial.
Vitamin D Supplementation and Cardiovascular Disease Risk.
Zittermann A, Pilz S. Zittermann A, et al. JAMA Cardiol. 2017 Nov 1;2(11):1280-1281. doi: 10.1001/jamacardio.2017.2935. JAMA Cardiol. 2017. PMID: 28854310 No abstract available.
Vitamin D Supplementation and Cardiovascular Disease Risk.
Anagnostis P, Paschou SA, Goulis DG. Anagnostis P, et al. JAMA Cardiol. 2017 Nov 1;2(11):1281-1282. doi: 10.1001/jamacardio.2017.2938. JAMA Cardiol. 2017. PMID: 28854312 No abstract available.